ClinicaliQ Trial Snapshot
- Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung Diseases — Recruiting • Respiratory / COPD / Asthma • NCT07615504.
- What is being tested: Non-invasive diagnostic assessments designed to improve diagnostic accuracy and prognostication in interstitial lung diseases (ILD), addressing current weaknesses in available testing methods.
- Patient eligibility overview: The trial focuses on patients with interstitial lung diseases who currently experience diagnostic delays and lack objective evidence to support immunosuppressive therapy decisions.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Patients with interstitial lung diseases (ILD) suffer significant delays in obtaining a diagnosis, and objective evidence of support for immunosuppressive therapies, due to weaknesses in the diagnostic tests available in ILD clinics. This project will assess several non-invasive assessments, focusing on blood and breath based sampling, to identify candidate tests that may translate through to routine clinical use. The tests being assessed will be initially employed in Pigeon Fanciers, a group recognised to be at high risk of developing ILD compared to age matched controls, due to their regular exposure…
Eligibility Snapshot
- : To participate subjects will either have to be active Pigeon Fanciers, or will be either attending ILD clinics for management of their interstitial lung disease or will present acutely to hospital services with severe respiratory failure due to ILD.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.